News
Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...
Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...
Novartis said it plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well ...
It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.
Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...
The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...
Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...
A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results